首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1357983

傷寒口服疫苗市場：按疫苗類型、按年齡層、按配銷通路、按最終用戶、按地區

Oral Typhoid Vaccine Market, By Vaccine Type, By Age Group, By Distribution Channel, By End-User, By geography

出版日期: 2023年09月21日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

傷寒口服疫苗市場規模預計將從 2023 年的 3,946.2 億美元增至 2030 年的 8,888.7 億美元，預測期內年複合成長率為 12.3%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	3946.2億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	12.30%	2030年市場規模預測	8888.7億美元

傷寒口服疫苗全球市場佔有率(%)，按地區，2023 年

傷寒是感染疾病，仍然是一個主要的全球健康問題，特別是在開發中國家。每年報告的病例超過 1000 萬例，考慮有效的預防措施至關重要，其中之一就是口服傷寒疫苗。

口服傷寒疫苗，也稱為Ty21a，因其預防傷寒的便利性和有效性而受到歡迎。與傳統的注射疫苗不同，這種創新疫苗是口服給藥，因此更容易分發和給藥，特別是在醫療保健設施有限的地區。

市場動態：

傷寒口服疫苗市場是由多種要素推動的。首先，全球傷寒罹患率不斷上升，需要採取有效的預防措施，增加了口服傷寒疫苗的需求。此外，人們對疫苗接種好處和公共衛生配合措施重要性的認知不斷提高也促進了市場的成長。

但市場也存在一定的抑制因素。這些挑戰之一是許多地區獲得衛生服務的機會有限，阻礙了口服傷寒疫苗的分發和給藥。此外，生產和分發疫苗的高成本也對覆蓋服務不足的人構成了障礙。

儘管有這些挑戰，傷寒口服疫苗市場仍具有廣泛的成長機會。開發具有成本效益的製造流程和簡化的分銷網路有助於克服准入障礙。此外，為提高口服傷寒疫苗的功效和安全性而進行的研究和開發工作也正在推動市場擴張。

本研究的主要特點

本報告對全球口服傷寒疫苗市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和平均年度（年複合成長率 %）。
它還揭示了各個細分市場的潛在收入機會，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球傷寒口服疫苗市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
全球傷寒口服疫苗市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球傷寒口服疫苗市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 394.62 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	12.30%	2030 Value Projection:	US$ 888.87 Bn

Typhoid fever, an infectious disease caused by the bacterium Salmonella typhi, remains a significant global health concern, particularly in developing countries. With over 10 million cases reported each year, it is crucial to explore effective preventive measures, one of which is the oral typhoid vaccine

The oral typhoid vaccine, also known as Ty21a, has gained popularity due to its convenience and effectiveness in preventing typhoid fever. Unlike traditional injectable vaccines, this innovative vaccine is administered orally, making it easier to distribute and administer, especially in areas with limited healthcare facilities.

Market Dynamics:

The oral typhoid vaccine market is driven by several factors. Firstly, the increasing global incidence of typhoid fever has created a need for effective preventive measures, thereby boosting the demand for oral typhoid vaccines. Additionally, the growing awareness about the benefits of vaccination and the importance of public health initiatives has contributed to market growth.

However, there are also certain restraints to the market. One such challenge is the limited access to healthcare services in many regions, hindering the distribution and administration of oral typhoid vaccines. Moreover, the high cost associated with vaccine production and distribution poses a barrier to reaching underserved populations.

Despite these challenges, the oral typhoid vaccine market holds promising opportunities for growth. The development of cost-effective manufacturing processes and streamlined distribution networks can help overcome access barriers. Furthermore, ongoing research and development efforts to enhance the efficacy and safety of oral typhoid vaccines can drive market expansion.

Key features of the study:

This report provides in-depth analysis of the global oral typhoid vaccine market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oral typhoid vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Oral Typhoid Vaccine market include Sanofi Pasteur, Bharat Biotech, Pfizer Inc., and GlaxoSmithKline (GSK), among others
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global oral typhoid vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oral typhoid vaccine market

Detailed Segmentation:

By Vaccine Type:
- Live Attenuated Vaccine
- Inactivated Vaccine
By Age Group:
- Pediatric Vaccines
- Adult Vaccines
By Distribution Channel:
- Hospitals and Clinics
- Pharmacies and Retail Outlets
- Government Immunization Programs
By End-User:
- Travelers
- Residents of Endemic Areas
- Healthcare Workers
By Geographic Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top companies in Oral Typhoid Vaccine Market:
- Sanofi Pasteur
- Bharat Biotech
- Pfizer Inc.
- GlaxoSmithKline (GSK)
- Baxter International Inc.
- Merck & Co., Inc. (MSD outside North America)
- Takeda Pharmaceutical Company Limited
- Novartis International AG
- Biological E. Limited
- AstraZeneca
- Cipla Limited
- Prokarium
- Bio-Med Pvt. Ltd.
- Panacea Biotec
- Dynavax Technologies Corporation
- Butantan Institute
- Zydus Cadila
- Biomed Pvt. Ltd.
- Cadila Healthcare Limited
- GlaxoSmithKline Biologicals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Oral Typhoid Vaccine, By Vaccine Type
- Market Oral Typhoid Vaccine, By Age Group
- Market Oral Typhoid Vaccine, By Distribution Channel
- Market Oral Typhoid Vaccine, By End-User
- Market Oral Typhoid Vaccine, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing awareness about the benefits of vaccination
- Limited Access in Low-Income Regions
- Expanding immunization programs in developing countries
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Oral Typhoid Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Oral Typhoid Vaccine Market , By Vaccine Type, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Live Attenuated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Oral Typhoid Vaccine Market , By Age Group, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Pediatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Adult Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

7. Oral Typhoid Vaccine Market , By Distribution Channel, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Pharmacies and Retail Outlets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Government Immunization Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Oral Typhoid Vaccine Market , By End-User, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Travelers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Residents of Endemic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Healthcare Workers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Oral Typhoid Vaccine Market , By Region, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)

10. Competitive Landscape

Sanofi Pasteur
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc. (MSD outside North America)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biological E. Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Others
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views